DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,811,498 | +7.2% | 144,343 | +3.7% | 0.47% | +7.5% |
| Q2 2023 | $33,411,600 | -0.6% | 139,215 | +4.4% | 0.44% | -14.1% |
| Q1 2023 | $33,602,729 | -2.1% | 133,323 | +3.1% | 0.51% | -11.6% |
| Q4 2022 | $34,332,342 | +9.8% | 129,351 | +6.8% | 0.58% | +1.6% |
| Q3 2022 | $31,274,000 | +10.0% | 121,080 | +8.0% | 0.57% | +13.8% |
| Q2 2022 | $28,435,000 | -3.2% | 112,162 | +12.0% | 0.50% | +9.4% |
| Q1 2022 | $29,377,000 | +7.3% | 100,149 | +20.4% | 0.46% | -9.2% |
| Q4 2021 | $27,372,000 | +6.7% | 83,194 | -1.2% | 0.50% | -5.5% |
| Q3 2021 | $25,648,000 | +13.6% | 84,247 | +0.2% | 0.53% | +15.2% |
| Q2 2021 | $22,573,000 | +46.0% | 84,113 | +22.4% | 0.46% | +11.4% |
| Q1 2021 | $15,463,000 | +13.2% | 68,698 | +11.7% | 0.41% | -4.6% |
| Q4 2020 | $13,663,000 | +19.1% | 61,506 | +15.5% | 0.43% | -9.8% |
| Q3 2020 | $11,468,000 | +39.8% | 53,256 | +14.8% | 0.48% | +14.0% |
| Q2 2020 | $8,203,000 | -8.4% | 46,387 | -27.1% | 0.42% | +5.2% |
| Q1 2020 | $8,958,000 | -11.5% | 63,615 | -3.5% | 0.40% | +12.3% |
| Q4 2019 | $10,123,000 | +1.2% | 65,956 | -4.8% | 0.36% | -3.5% |
| Q3 2019 | $10,002,000 | +58.0% | 69,252 | +56.4% | 0.37% | +2.8% |
| Q2 2019 | $6,329,000 | +18.2% | 44,281 | +9.1% | 0.36% | +4.7% |
| Q1 2019 | $5,356,000 | +43.1% | 40,570 | +11.8% | 0.34% | +13.5% |
| Q4 2018 | $3,742,000 | +4.2% | 36,288 | +9.8% | 0.30% | +11.0% |
| Q3 2018 | $3,592,000 | +29.0% | 33,055 | +17.1% | 0.27% | +3.8% |
| Q2 2018 | $2,784,000 | +46.0% | 28,216 | +44.9% | 0.26% | -4.0% |
| Q1 2018 | $1,907,000 | +17.3% | 19,476 | +11.2% | 0.27% | +6.6% |
| Q4 2017 | $1,626,000 | +8.6% | 17,520 | +0.4% | 0.26% | +1.6% |
| Q3 2017 | $1,497,000 | +3.9% | 17,457 | +2.2% | 0.25% | -2.3% |
| Q2 2017 | $1,441,000 | +33.5% | 17,077 | +35.3% | 0.26% | -5.1% |
| Q1 2017 | $1,079,000 | +74.6% | 12,621 | +59.0% | 0.27% | -6.2% |
| Q4 2016 | $618,000 | – | 7,940 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |